Viveve Medical (VIVE) Misses Q2 EPS by 11c, Miss on Revenues

Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.54), $0.11 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.24 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus